Home
>
National Drug Code (NDC)
>
REOPRO
REOPRO - 0002-7140-01 - (abciximab)
Drug Information of REOPRO
| Product NDC: | 0002-7140 |
| Proprietary Name: | REOPRO |
| Non Proprietary Name: | abciximab |
| Active Ingredient(s): | 2 mg/mL & nbsp; abciximab |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of REOPRO
| Product NDC: | 0002-7140 |
| Labeler Name: | Eli Lilly and Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103575 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19931216 |
Package Information of REOPRO
| Package NDC: | 0002-7140-01 |
| Package Description: | 5 mL in 1 VIAL, SINGLE-USE (0002-7140-01) |
NDC Information of REOPRO
| NDC Code | 0002-7140-01 |
| Proprietary Name | REOPRO |
| Package Description | 5 mL in 1 VIAL, SINGLE-USE (0002-7140-01) |
| Product NDC | 0002-7140 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | abciximab |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19931216 |
| Marketing Category Name | BLA |
| Labeler Name | Eli Lilly and Company |
| Substance Name | ABCIXIMAB |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
